Straits Times Index
3,293.53 +0.84 (+0.03%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,207.13 +444.10 (+2.50%) FTSE 100
8,151.71 +30.47 (+0.38%) Bitcoin USD
57,810.04 +796.97 (+1.40%) CMC Crypto 200
1,267.43 -3.32 (-0.26%)
Dyadic International, Inc. (DYAI)
| Previous close | 1.5100 |
| Open | 1.4900 |
| Bid | 1.0800 x 200 |
| Ask | 1.9000 x 200 |
| Day's range | 1.3900 - 1.4901 |
| 52-week range | 1.1900 - 2.4000 |
| Volume | |
| Avg. volume | 22,465 |
| Market cap | 42.978M |
| Beta (5Y monthly) | 0.59 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.2400 |
| Earnings date | 14 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
GlobeNewswireDyadic to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024
JUPITER, Fla., April 30, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the efficient large-scale manufacture of proteins for use in human and animal vaccines and therapeutics, as well as in non-pharmaceutical applications including food, nutrition, and wellness, today announced that it will report its financial results for the first quarter 2024 and host a corporate update conference call on
Insider MonkeyDyadic International, Inc. (NASDAQ:DYAI) Q4 2023 Earnings Call Transcript
Dyadic International, Inc. (NASDAQ:DYAI) Q4 2023 Earnings Call Transcript March 28, 2024 Dyadic International, Inc. misses on earnings expectations. Reported EPS is $-0.08 EPS, expectations were $-0.07. DYAI isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good evening, and welcome […]
- Thomson Reuters StreetEvents
Q4 2023 Dyadic International Inc Earnings Call
Q4 2023 Dyadic International Inc Earnings Call
